Diligence memo · auto-generated · as of July 2, 2026

Apreo Health, Inc.

Apreo Health, Inc. looks over-valued against its niche peers and is active on financing cadence.

WatchModeled above niche peers — entry today likely prices in growth not yet evidenced in the filings.

Businessfiled

Apreo Health, Inc. operates in Healthtech, based in MENLO PARK.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Apreo Health, Inc. has raised $82M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).

Largest single filing: $82M on 2025-08-06.

Most recent recorded round closed around 2025-08-06.

Valuation (modeled)modeled

Provath models Apreo Health, Inc. at approximately $513M (range $297M–$671M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 1.55× the median modeled value of Series C Healthtech companies in 2025–2027 (19 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Last raise 11 mo ago; this sector typically re-raises about every 14 months.

Raising on or ahead of the sector's normal rhythm.

Comparablesmixed

Capital scale ranks ahead of 95% of Healthtech peers (2138 compared).

Modeled value ranks above 93% of those peers.

Closest niche peers: Thyme Care, Inc., Cohere Health Inc., All Inspire Health, Inc., Harbor Health Team Inc., 4C Medical Technologies, Inc..

Peoplefiled

6 named people on file across officers, directors and signatories.

Risks & flagsmixed

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.